Video: Page (1) of 1 - 01/03/13

Analyst Moves: BIIB, GEVA

By DMO Affiliate

Biogen Idec (BIIB) was downgraded by Piper Jaffray (PJC) to neutral from overweight, as the share price has been approacing the previously set $168 price target. Shares are lower by about 1.3 percent.
Analyst Moves: BIIB, GEVA



null

Related Keywords:BIIB, PJC, GEVA, Business, Personal Finance, Analyst News

Source:GrabNetworks (c). All Rights Reserved

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved

Webmaster
Privacy.